@article{4a6f38d6061d479394c17ece16a2448c,
title = "Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials",
keywords = "Prospective Studies, Double-Blind Method, Intravitreal Injections, Humans, Macular Degeneration/complications, Middle Aged, Male, Treatment Outcome, Geographic Atrophy/diagnosis, Visual Acuity, Immunoglobulin Fab Fragments/adverse effects, Complement Factor D/antagonists \& inhibitors, Aged, 80 and over, Female, Aged, Fluorescein Angiography",
author = "\{the Chroma and Spectri Study Investigators\} and Holz, \{Frank G.\} and Sadda, \{Srinivas R.\} and Brandon Busbee and Chew, \{Emily Y.\} and Paul Mitchell and Adnan Tufail and Christopher Brittain and Daniela Ferrara and Sarah Gray and Lee Honigberg and Jillian Martin and Barbara Tong and Ehrlich, \{Jason S.\} and Bressler, \{Neil M.\} and Sola, \{Federico Furno\} and Patricio Schlottmann and Alberto Zambrano and Carlos Zeolite and Jennifer Arnold and Mark Gillies and Alan Luckie and Paul Mitchell and Nicole Schneltzer and \{de Zaeytijd\}, Julie and Shelley Boyd and Alan Cruess and Peter Kertes and Laurent Lalonde and David Maberley and Caroline Laugesen and Bahram Bodaghi and Cohen, \{Salomon Yves\} and Catherine Francais and Eric Souied and Ramin Tadayoni and Lebriz Altay and Nicole Eter and Nicolas Feltgen and Carsten Framme and Salvatore Grisanti and Daniel Pauleikhoff and Andr{\'a}s Seres and Attila Vajas and Balazs Varsanyi and Francesco Boscia and Parravano, \{Maria Cristina\} and Federico Ricci and Francesco Viola and Rechy, \{David Lozano\} and Clement Chan",
note = "Publisher Copyright: {\textcopyright} 2018 American Medical Association. All rights reserved.",
year = "2018",
month = jun,
doi = "10.1001/jamaophthalmol.2018.1544",
language = "English",
volume = "136",
pages = "666--677",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
number = "6",
}